![]() |
|
|
Molecular Pharmacology, Vol 18, 395-401, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Neuropharmacology, Max-Planck-Institut für Psychiatrie, Kraepelinstrasse 2, D-8000 München 40,
Federal Republic of Germany
The development of opiate tolerance has been studied in the mouse vas deferens, which
contains µ- and
-opiate receptors. Long-term infusion of opioids acting selectively on
either µ- or
-receptors was accomplished by means of osmotic minipumps. In vitro tests
of vasa deferentia from chronically [D-Ala2,D-Leu5]enkephalin (DADL)-treated mice
revealed an 800-fold degree of tolerance for
-receptors, while µ-receptors were left
unaffected. Accordingly, cross-tolerance to
-receptor agonists, e.g., leucine-enkephalin,
was observed but not to µ-receptor agonists, e.g., normorphine. On the other hand,
infusion of the potent opioid sufentanyl, which almost selectively acts at µ-receptors,
brings about a high degree of tolerance for µ-receptor agonists, but causes no change in
sensitivity to
-receptor agonists. A number of opioids, including
-endorphin, exhibit
some degree of cross-tolerance in
-receptor-tolerant as well as in µ-receptor-tolerant
preparations. Essentially identical results were obtained in vasa deferentia made acutely
tolerant in vitro using the
-receptor agonist DADL. Challenge of highly tolerant vasa
deferentia with the narcotic antagonist naloxone failed to demonstrate any withdrawal
sign. The failure to demonstrate dependence in highly tolerant vasa deferentia may be
due to adaptational processes upon chronic opioid exposure at the opiate receptor binding
site level. It is concluded that opiate receptor differentiation can be reliably achieved by
means of their selective tolerance development.
Note:
ACKNOWLEDGMENTS
The expert technical assistance of Ms. A. Wilhelm is greatly appreciated. We would like to thank Dr. J. Dum for stylistic corrections of
the manuscript. We are grateful to Dr. Heykants for donating sufentanyl and to Dr. Ling for a gift of
-lipotropin61-79.
This article has been cited by other articles:
![]() |
K. Rice, A. Jacobson, T. Burke Jr, B. Bajwa, R. Streaty, and W. Klee Irreversible ligands with high selectivity toward delta and mu opiate receptors Science, April 15, 1983; 220(4594): 314 - 316. [Abstract] [PDF] |
||||